If you have been reading about GRF(1-29) and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-10-17. Numbers and descriptions here follow the published literature rather than marketing material.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
| Property | Value | Notes |
|---|---|---|
| Physical form | Lyophilized white powder | Supplied as a freeze-dried solid for research use |
| Molecular weight | Approximately 3,647 Da (DAC form) | Lower for the variant lacking the albumin-binding moiety |
| Solubility | Soluble in water and aqueous buffer | Typically dissolved in sterile or bacteriostatic water |
| Typical storage temperature | −20 °C or below | Dry powder, desiccated and protected from light |
| Common analytical method | Reversed-phase HPLC with mass spectrometry | Used for purity estimation and identity confirmation |
CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.
The attached maleimide group explains the unusual duration of the DAC version. After injection it reacts with the thiol of cysteine-34 on serum albumin, forming a stable covalent bond. The resulting conjugate is too large for rapid kidney filtration and is shielded from many peptidases. Reported half-lives for this form reach several days, whereas the version without the group is cleared in roughly half an hour. That gap is the main pharmacological difference between the two.
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.
== Alpha and beta particles == 𝜶 and β particles are both used in the treatment of cancers, depending on the size and location of the particular tumor. Alpha particles contain overall higher energy and have a shorter path length, and have greater cytotoxic properties for this reason as compared to β particles. However, due to the shorter path length of these particles, the method of delivery needs to be extremely close to the location of the tumor. Currently, treatments using alpha emitters exist which consist of alpha emitters attached to carrier molecules. Some examples of alpha-emitting radioligands include actinium-225, Ra-223-chloride, and Lead-212.36
In 2014, Buc-ee's filed a lawsuit against Texas-based convenience store chain "Frio Beaver". Frio Beaver, a company with a logo also depicting a beaver in a yellow circle with a black outline, was accused of copying the Buc-ee's beaver head logo, which the company is widely known for in Texas. The case was settled out of court in December 2014; B&B Grocery Inc. agreed to stop using the "Frio Beaver" logo and mascot. In 2016, Buc-ee's sued "Choke Canyon BBQ", another Texas convenience store, for copyright infringement and trade dressing. Choke Canyon used a logo of a grinning alligator in the middle of a yellow circle, which Buc-ee's claimed was an attempt by the chain to resemble the Buc-ee's logo. Choke Canyon was also calling its new stores "Bucky's". Choke Canyon lost the federal lawsuit in May 2018, with Choke Canyon changing its logo to a cowboy inside of an orange circle. In 2017, Buc-ee's again filed a lawsuit for breaking an agreement, this time against a Nebraska-based convenience store chain known as "Bucky's". The two companies had agreed to remain in their respective states and expand only to states where the other did not operate. The lawsuit was thrown out. A non-logo related lawsuit was filed in 2013 against "Chicks", a convenience store in Bryan, Texas, for trade dress violations by allegedly copying Buc-ee's mega convenience store designs and layout. The case was settled out of court.
== Characterization == Characterization techniques for copolymers are similar to those for other polymeric materials. These techniques can be used to determine the average molecular weight, molecular size, chemical composition, molecular homogeneity, and physiochemical properties of the material. However, given that copolymers are made of base polymer components with heterogeneous properties, this may require multiple characterization techniques to accurately characterize these copolymers. Spectroscopic techniques, such as nuclear magnetic resonance spectroscopy (NMR), infrared spectroscopy (IR), and UV spectroscopy, are often used to identify the molecular structure and chemical composition of copolymers. NMR can be used to determine a number of polymer characteristics, including tacticity and repeat unit sequence, predominantly using 1H and 13C NMR. NMR can also be used for analysis of the end groups and branching points within polymer chains, which can provide information both about size and branching pattern. IR spectroscopy is primarily used to identify functional groups attached to a copolymer, but it can also provide information about the degree of branching within a copolymer. UV spectroscopy can be used to determine the concentration of a chromophore-containing monomer within a polymer resin. UV spectroscopy is commonly used as a detector with size-exclusion chromatography. Scattering techniques, such as static light scattering, dynamic light scattering, and small-angle neutron scattering, can determine the molecular size and weight of the synthesized copolymer.
Sources: en.wikipedia.org
Proprotein convertases (PPCs) are a family of proteins that activate other proteins. Many proteins are inactive when they are first synthesized, because they contain chains of amino acids that block their activity. Proprotein convertases remove those chains and activate the protein. The prototypical proprotein convertase is furin. Proprotein convertases have medical significance, because they are involved in many important biological processes, such as cholesterol synthesis. Compounds called proprotein convertase inhibitors can block their action, and block the target proteins from becoming active. Many proprotein convertases, especially furin and PACE4, are involved in pathological processes such as viral infection, inflammation, hypercholesterolemia, and cancer, and have been postulated as therapeutic targets for some of these diseases.
== Academia == In 2004, Peña taught as an adjunct professor at the Catholic University of Asunción, teaching financial theory. In 2005, he became a professor of economic policy at the same establishment. In addition, Peña has contributed to scholarship on monetary policy and finance. In 2017, he was invited by the Professor and current Ecuadorian ambassador to Chile Roberto Izurieta to participate as a visiting professor at the Graduate School of Political Management of the George Washington University in Washington D.C., where Peña shared his experience on public administration in Paraguay. He also was the thesis advisor of Geovanny Vicente, CNN columnist and professor at Columbia University.
The gingiva often possess a textured surface that is referred to as being stippled (engraved points). Stippling only presents on the attached gingiva bound to underlying alveolar bone, not the freely moveable alveolar mucosa or free gingiva. Stippling used to be thought to indicate health, but it has since been shown that smooth gingiva is not an indication of disease, unless it is smooth due to a loss of previously existing stippling. Stippling is a consequence of the microscopic elevations and depressions of the surface of the gingival tissue due to the connective tissue projections within the tissue. The degree of keratinization and the prominence of stippling appear to be related. To be more specific, stippling occurs at sites of fusion of the epithelial ridges (also known as rete pegs – depression of epithelium) and correspond to the fusion of the valleys created by the connective tissue papillae (elevation of connective tissue papilla). An example of stippling could be dots found on a basketball or an orange.
Sources: en.wikipedia.org
The two share the same 29-amino-acid backbone. CJC-1295 carries an additional albumin-binding moiety that markedly extends its residence time in circulation, while the form without that moiety clears faster. Literature sometimes applies the name loosely to either variant.
It has not been approved by major regulatory agencies for any therapeutic indication. Material sold under this name is typically distributed for laboratory research only. Clinical use is not supported by large controlled trials.
Early human studies of the albumin-binding form reported circulation half-lives on the order of several days. The value depends on assay method and study design. Estimates for the form without the binding moiety are considerably shorter.
Reported values cluster in the range of several days, reflecting slow release from the albumin complex. Estimates differ across species and assay platforms. The figure describes circulation time in study settings rather than a fixed property.